196 related articles for article (PubMed ID: 32103934)
1. Serum IL-8 and VEGFA are Two Promising Diagnostic Biomarkers of Asthma-COPD Overlap Syndrome.
Ding Q; Sun S; Zhang Y; Tang P; Lv C; Ma H; Yu Y; Xu S; Deng Z
Int J Chron Obstruct Pulmon Dis; 2020; 15():357-365. PubMed ID: 32103934
[TBL] [Abstract][Full Text] [Related]
2. The relationship between inflammatory markers and spirometric parameters in ACOS, Asthma, and COPD.
Uzan GC; Borekci S; Doventas YE; Koldas M; Gemicioglu B
J Asthma; 2020 Dec; 57(12):1273-1279. PubMed ID: 31403365
[No Abstract] [Full Text] [Related]
3. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
[TBL] [Abstract][Full Text] [Related]
4. Plasma Inflammatory Cytokine IL-4, IL-8, IL-10, and TNF-α Levels Correlate with Pulmonary Function in Patients with Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome.
Huang AX; Lu LW; Liu WJ; Huang M
Med Sci Monit; 2016 Aug; 22():2800-8. PubMed ID: 27501772
[TBL] [Abstract][Full Text] [Related]
5. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
Deng DD; Zhou AY; Shuang QC; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
[No Abstract] [Full Text] [Related]
6. Longitudinal analysis to better characterize Asthma-COPD overlap syndrome: Findings from an adult asthma cohort in Korea (COREA).
Park SY; Jung H; Kim JH; Seo B; Kwon OY; Choi S; Oh B; Kwon HS; Cho YS; Moon HB; Won S; Park T; Kim TB
Clin Exp Allergy; 2019 May; 49(5):603-614. PubMed ID: 30657218
[TBL] [Abstract][Full Text] [Related]
7. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
Albertson TE; Chenoweth JA; Pearson SJ; Murin S
Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
[No Abstract] [Full Text] [Related]
8. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD.
Chen FJ; Huang XY; Liu YL; Lin GP; Xie CM
Int J Chron Obstruct Pulmon Dis; 2016; 11():2385-2390. PubMed ID: 27713629
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
[TBL] [Abstract][Full Text] [Related]
10. The Plasma Levels of hsa-miR-19b-3p, hsa-miR-125b-5p, and hsamiR- 320c in Patients with Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS).
Bersimbaev R; Aripova A; Bulgakova O; Kussainova А; Akparova A; Izzotti A
Microrna; 2021; 10(2):130-138. PubMed ID: 34151771
[TBL] [Abstract][Full Text] [Related]
11. [Asthma-chronic obstructive pulmonary disease overlap syndrome: clinical-functional profile].
Che-Morales JL; Valle-Piña J; Carrillo-Chan J
Rev Med Inst Mex Seguro Soc; 2019 Sep; 57(5):284-290. PubMed ID: 32568483
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of asthma and COPD overlap syndrome (ACOS) in the Canadian population.
Senthilselvan A; Beach J
J Asthma; 2019 Nov; 56(11):1129-1137. PubMed ID: 30359154
[No Abstract] [Full Text] [Related]
13. Clinical characteristics of the asthma-COPD overlap syndrome--a systematic review.
Nielsen M; Bårnes CB; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():1443-54. PubMed ID: 26251584
[TBL] [Abstract][Full Text] [Related]
14. Asthma-COPD overlap syndrome (ACOS): A diagnostic challenge.
Tho NV; Park HY; Nakano Y
Respirology; 2016 Apr; 21(3):410-8. PubMed ID: 26450153
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic impact of asthma, chronic obstructive pulmonary disease and asthma-COPD overlap syndrome.
Kim J; Kim YS; Kim K; Oh YM; Yoo KH; Rhee CK; Lee JH
J Thorac Dis; 2017 Jun; 9(6):1547-1556. PubMed ID: 28740668
[TBL] [Abstract][Full Text] [Related]
16. Current situation of asthma-COPD overlap syndrome (ACOS) in Chinese patients older than 40 years with airflow limitation: rationale and design for a multicenter, cross-sectional trial (study protocol).
Kang J; Yao W; Cai B; Chen P; Ling X; Shang H
J Thorac Dis; 2016 Dec; 8(12):3744-3751. PubMed ID: 28149573
[TBL] [Abstract][Full Text] [Related]
17. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
[TBL] [Abstract][Full Text] [Related]
18. Current situation of asthma-COPD overlap in Chinese patients older than 40 years with airflow limitation: a multicenter, cross-sectional, non-interventional study.
Kang J; Zheng J; Cai B; Wen F; Yao W; Zhang X; Chen Y; Wang G; Li W; Cao J
Ther Adv Respir Dis; 2020; 14():1753466620961699. PubMed ID: 33103591
[TBL] [Abstract][Full Text] [Related]
19. Sputum Neutrophil Gelatinase-Associated Lipocalin as a Biomarker in Asthma-COPD Overlap.
Babu A; Narayanswamy H; Baburao A
J Assoc Physicians India; 2023 Sep; 71(9):34-38. PubMed ID: 38700299
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome.
Guo Y; Hong C; Liu Y; Chen H; Huang X; Hong M
Medicine (Baltimore); 2018 Jun; 97(23):e10857. PubMed ID: 29879019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
